Compounds, pharmaceutical compositions, kits and methods useful for
inhibiting HDAC, thereby treating a disease state for which HDAC possess
activity that contributes to the pathology and/or symptomology of the
disease state. The compound is selected from the group consisting of:
##STR00001## wherein the variables are as defined herein.